ClassID:

110843

C12N2760/16252 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus B, i.e. influenza B virus; Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Recent Application in this class:
#1
20250090650
2025-03-20

MODIFIED INFLUENZA B HEMAGGLUTININ POLYPEPTIDES AND NUCLEIC ACIDS AND USES THEREOF

#2
20220242918
2022-08-04

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

#3
20220127582
2022-04-28

Proliferation method

#4
20200332264
2020-10-22

SO3 chromatography for use in a method for virus purification

#5
20200263142
2020-08-20

Generation of infectious influenza viruses from virus-like particles

#6
20200223892
2020-07-16

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

#7
20200215184
2020-07-09

Influenza virus reassortment

#8
20200010830
2020-01-09

Engineered cells with decreased gene expression resulting in increased viral production

#9
20180298063
2018-10-18

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

#10
20170369853
2017-12-28

FORMULATION OF SUGAR SOLUTIONS FOR CONTINUOUS ULTRACENTRIFUGATION FOR VIRUS PURIFICATION

#11
20170304428
2017-10-26

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

#12
20160108367
2016-04-21

MDCK-derived cell strain suspension-cultured in protein-free medium and method for proliferating virus using cell strain

#13
20160060603
2016-03-03

Formulation of sugar solutions for continuous ultracentrifugation for virus purification

#14
20160038585
2016-02-11

Influenza virus reassortment

#15
20150247128
2015-09-03

MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells

#16
20130189762
2013-07-25

Multi plasmid system for the production of influenza virus

#17
20130052717
2013-02-28

MDCK cell lines supporting viral growth to high titers and bioreactor process using the same

#18
20120238000
2012-09-20

Immortalized avian cell lines

#19
20120196371
2012-08-02

Multi plasmids system for the production of influenza virus

#20
20120039939
2012-02-16

COMPOSITIONS AND METHODS FOR VACCINE AND VIRUS PRODUCTION

#21
20110008872
2011-01-13

Immortalized avian cell lines

#22
20100239609
2010-09-23

Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification

#23
20100145015
2010-06-10

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

#24
20100112669
2010-05-06

Method of purifying influenza virus and removing MDCK cell DNA contaminants

#25
20090208527
2009-08-20

Multi plasmid system for the production of influenza virus

#26
20080286850
2008-11-20

MDCK CELL LINES SUPPORTING VIRAL GROWTH TO HIGH TITERS AND BIOREACTOR PROCESS USING THE SAME

#27
20080274138
2008-11-06

Formulation of sugar solutions for continuous ultracentrifugation for virus purification

#28
20050158342
2005-07-21

Multi plasmid system for the production of influenza virus